If you are considering taking part in a clinical trial at ALYATEC, you will find below the list of ongoing studies:
Study ALY-ALK001: birch pollen rhinitis
Who is eligible? Adolescents aged 12 to 17 having symptoms of allergic rhinitis or rhinoconjunctivitis to birch pollen.
What is the purpose of the study? To identify the allergic profile of adolescent patients allergic to birch pollen.
When? Inclusion of participants from April 20 to August 31, 2026.
What else? Compensation of 50€ for two visits (30 minutes + 1 hour) to be carried out at ALYATEC.
PALPEBRAL Study: Atopic Dermatitis
Who is eligible? Adults experiencing symptoms of atopic dermatitis affecting the face and/or neck, whether or not they are treated with topical corticosteroids.
What is the purpose of the study? To demonstrate the tolerance and effectiveness of the dermocosmetic product Palpebral Balm in reducing symptoms of mild to moderate atopic dermatitis.
When? Participant inclusion from January 27 to April 26, 2026.
What else? Compensation of €40 per visit. Between 3 and 4 visits, each lasting no more than one hour, to be carried out at ALYATEC over a period of 4 to 8 weeks.
DIA-001 Study: Cat Allergy
Who is eligible? Adults with allergic conjunctivitis caused by cat allergens.
What is the purpose of the study? To detect the presence of biomarkers specific to cat allergy in the tear fluid of patients with allergic conjunctivitis.
When? Study conducted between February and May 2026.
What else? Compensation ranging from €80 to €120, depending on the number of biological sample collections. Two to three appointments at ALYATEC, to be completed within a maximum of two days.
Upcoming clinical studies
Additional clinical studies will be starting soon at ALYATEC, particularly in the areas of atopic dermatitis (eczema) and food allergies (peanuts, hazelnuts, walnuts, sesame, fish, soy, egg, wheat, etc.).
Please feel free to contact us to schedule an appointment and register in our volunteer database.
You may also refer friends or family members to participate in a study and earn €50 through our referral program.